Home > Boards > US Listed > Biotechs > Teva Pharmaceutical (TEVA)

Interesting analysis. Here is mine:

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
NoMoDo Member Profile
Member Level 
Followed By 108
Posts 5,724
Boards Moderated 1
Alias Born 03/15/02
160x600 placeholder
L'engagement de Teva Canada envers les proches aidants canadiens PR Newswire (Canada) - 4/7/2020 7:30:00 AM
Teva Canada Committed to Canadian Caregivers PR Newswire (Canada) - 4/7/2020 7:30:00 AM
Teva to Donate Potential COVID-19 Treatment, Hydroxychloroquine Sulfate Tablets to Hospitals Nationwide Business Wire - 3/19/2020 8:23:00 PM
Teva and Celltrion Healthcare Announce U.S. Availability of HERZUMA® (trastuzumab-pkrb) for Injection Business Wire - 3/16/2020 8:00:00 AM
Avis favorable de l'Institut national pour l'excellence clinique (NICE) pour le premier traitement anti-PRGC de la migraine :... Business Wire - 3/12/2020 12:14:00 PM
Positive Empfehlung des NICE für die erste, gegen das CGRP gerichtete Migränetherapie: AJOVY®▼ (Fremanezumab) Business Wire - 3/12/2020 12:03:00 PM
Positive Recommendation by NICE for first anti-CGRP migraine therapy: AJOVY®▼ (fremanezumab) Business Wire - 3/12/2020 3:30:00 AM
Teva Gets FDA Approval for ArmonAir Digihaler Inhalation Powder Dow Jones News - 2/24/2020 9:13:00 AM
Teva Announces FDA Approval of ArmonAir® Digihaler™ (fluticasone propionate) Inhalation Powder Business Wire - 2/24/2020 8:00:00 AM
Teva Announces Registration Trials of Deutetrabenazine in Pediatric Patients with Tourette Syndrome Did Not Meet the Primary ... Business Wire - 2/19/2020 4:05:00 PM
New Report Shows Teva Generic Medicines Saved US Healthcare System $41.9 Billion Business Wire - 2/12/2020 7:30:00 AM
Teva Reports Fourth Quarter and Full Year 2019 Financial Results Business Wire - 2/12/2020 7:00:00 AM
テバが日本でのAJOVY®(フレマネズマブ)の臨床試験の良好なトップライン結果を発表 Business Wire - 2/6/2020 1:14:00 AM
Teva Announces Positive Top-Line Results from AJOVY® (fremanezumab) Clinical Trials in Japan Business Wire - 2/3/2020 3:30:00 AM
Teva Says FDA Approves Ajovy Autoinjector Dow Jones News - 1/28/2020 5:16:00 PM
Teva Announces FDA Approval of AJOVY® (fremanezumab-vfrm) Injection Autoinjector Business Wire - 1/28/2020 4:05:00 PM
Teva to Host Conference Call to Discuss Fourth Quarter 2019 Financial Results & 2020 Financial Guidance at 8 a.m. ET on Febru... Business Wire - 1/15/2020 5:00:00 PM
Endo Agrees to Pay $8.8 Million to Settle Oklahoma Opioid Case Dow Jones News - 1/10/2020 2:18:00 PM
Teva to Present at the 38th Annual J.P. Morgan Healthcare Conference Business Wire - 1/6/2020 5:22:00 PM
Drug Prices Climb by 5.8% on Average, Less Than Last Year Dow Jones News - 1/2/2020 4:26:00 PM
NexImmune Appoints Sol Barer as Chairman of the Board of Directors GlobeNewswire Inc. - 12/16/2019 7:30:10 AM
Opioid Makers Hit With Criminal Probe -- WSJ Dow Jones News - 11/27/2019 3:02:00 AM
Opioid Makers, Distributors Fall Following WSJ Report on Federal Probe Dow Jones News - 11/26/2019 1:51:00 PM
Federal Prosecutors Launch Criminal Probe of Opioid Makers, Distributors Dow Jones News - 11/26/2019 1:18:00 PM
Teva Announces Early Tender Results of its Debt Tender Offer and Election of Early Settlement Business Wire - 11/25/2019 8:00:00 AM
NoMoDo Member Level  Thursday, 03/26/20 11:22:00 PM
Re: JLS post# 3391
Post # of 3469 
Interesting analysis. Here is mine:

Support at 7.91, 7.75
Resistance at 8.09, 8.35, 8.90 (also currently 200 dma)
MACD lagging indicator - positive crossover on daily at close
Stoch is a leading indicator - turned up on March 18 for daily with decent potential upside
RSI of no consequence - 50 on 30 min and 40 on daily

On 30 minute:
Stoch turned up at 3pm today potential for good day tomorrow
Support tends to follow the 50 ma
Resistance tends to follow the 200 ma
Potential for a golden cross tomorrow or Monday - meaning
Potential for a short term pinch

Weekly Stoch still negative, but converging quickly.

There is a potential breakout over the next couple of days. May have a second try at breaking through 8.35. Looking to test 8.90 very soon. Keep an eye on the daily and weekly Stoch.

Tuesday is March 31. Teva announced that they will have 6 mil hydrochloroquine and chloroquine tablets to hospitals by Tuesday. A PR would be expected. This could be a catalyst to push it over 8.90. Otherwise, expect heavy resistance in that range.






Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist